Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Neostigmine Methylsulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47,706Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3DR REDDYS

    02 2ADAPTIS

    03 2AM REGENT

    04 2AMNEAL

    05 2AMPHASTAR PHARMS INC

    06 2AMRING PHARMS

    07 2AVET LIFESCIENCES

    08 2BE PHARMS

    09 2CAPLIN

    10 2ENDO OPERATIONS

    11 4EUGIA PHARMA

    12 3EXELA PHARMA

    13 3FRESENIUS KABI USA

    14 2GLAND PHARMA LTD

    15 3HIKMA

    16 2MEITHEAL

    17 2SAGENT PHARMS INC

    18 2UMEDICA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    DR REDDYS

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Approval Date : 2018-07-10

    Application Number : 209135

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DR REDDYS

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Approval Date : 2018-07-10

    Application Number : 209135

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    DR REDDYS

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Approval Date : 2022-07-06

    Application Number : 216291

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    EXELA PHARMA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    EXELA PHARMA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Approval Date : 2013-05-31

    Application Number : 204078

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    EXELA PHARMA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    EXELA PHARMA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Approval Date : 2013-05-31

    Application Number : 204078

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    EXELA PHARMA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    EXELA PHARMA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    NEOSTIGMINE METHYLSULFATE

    Brand Name : BLOXIVERZ

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/5ML (1MG/ML)

    Approval Date : 2023-10-27

    Application Number : 204078

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    FRESENIUS KABI USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    FRESENIUS KABI USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Approval Date : 2015-01-08

    Application Number : 203629

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    FRESENIUS KABI USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    FRESENIUS KABI USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 10MG/10ML (1MG/ML)

    Approval Date : 2015-01-08

    Application Number : 203629

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    FRESENIUS KABI USA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    FRESENIUS KABI USA

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 3MG/3ML (1MG/ML)

    Approval Date : 2018-09-18

    Application Number : 203629

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    HIKMA

    United Kingdom
    2024 ACI Convention
    Not Confirmed
    arrow

    HIKMA

    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AP

    NEOSTIGMINE METHYLSULFATE

    Brand Name : NEOSTIGMINE METHYLSULFATE

    Dosage Form : SOLUTION;INTRAVENOUS

    Dosage Strength : 5MG/10ML (0.5MG/ML)

    Approval Date : 2015-12-28

    Application Number : 207042

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AP

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF